Miners say red tape is making Australia uncompetitive, but the same can't be said of Nevada, where junior goldie James Bay is ...

One of the big stories for ASX healthcare sector this week is Sonic Healthcare's deal to buy a major German medical ...

While drilling is underway at Target area 7, Raiden also expects to imminently receive results from earlier drilling at ...

The ASX ended lower after a stronger-than-expected jobs report, Downer EDI and Ventia shares after price-fixing allegations ...

Rio Tinto has reinforced its conviction lithium prices will rebound, pledging US$2.5bn to build the 60,000tpa Rincon project ...

Heavy transport and displacing fossil fuel-derived hydrogen are some of the key areas where clean hydrogen can shine.

ASX small caps could rebound in 2025, Shaw and Partners says, with lower interest rates boosting growth, plus diversification ...

The ASX drops as Wall Street weakness weighs on sentiment, with Insignia and Iress outperforming, Rio Tinto slumping.

Syntara hopes to emulate the success of Ojjaara, a $2.6 billion home-grown myelofibrosis therapy approved in the US.

What are your chances of finding good, reasonably priced financial advice? If we believe the headlines, the prospects have ...

More niobium rich surface samples have punters hoping for something big from Aldoro's diamond drilling at the Kameelburg ...

It may seem counterintuitive to say that US stocks will lead the world again in 2025. But that’s what's on the cards, says ...